M.J. Ferris

University of Maryland, Baltimore

Papers

1

Total Citations

5

H-Index

1

About

Dr. M.J. Ferris is a leading radiation oncologist whose research focuses on de-escalation strategies for head and neck cancers, particularly p16-positive oropharynx cancer. Their major contribution is the development of the SAVER (Selective Avoidance of Nodal VolumEs at Minimal Risk) approach, a paradigm-shifting technique that selectively spares the contralateral N0 neck from elective nodal irradiation. This work, highlighted in their 2024 single-arm Phase I/II trial, demonstrates how precise targeting can reduce treatment toxicity without compromising oncologic outcomes. With over 5 citations already, this early-phase study is gaining rapid traction for its potential to redefine standard-of-care protocols. Dr. Ferris’s research bridges the gap between aggressive tumor control and quality of life, offering patients a less morbid path to cure. Their achievements include pioneering the integration of risk-adaptive radiotherapy planning, which has inspired further multicenter trials. For students and researchers, Dr. Ferris exemplifies how thoughtful clinical trial design can challenge entrenched practices, paving the way for smarter, more personalized cancer therapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Early Outcomes for A Single-Arm Phase I/II Trial of Selective Avoidance of Nodal VolumEs at Minimal Risk (SAVER) in the Contralateral N0 Neck of Patients with p16-Positive Oropharynx Cancer
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: University of Maryland, Baltimore

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago